Royalty Pharma Plc (RPRX) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Royalty Pharma Plc (RPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($702.62 Million) in capital expenditures ($1.11 Million). See Royalty Pharma Plc (RPRX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$702.62 Million
USD
Capital Expenditures
$1.11 Million
USD
Data as of
Sep 2025
Most recent filing
Royalty Pharma Plc Capital Reinvestment Ratio (2002–2023)
This chart tracks Royalty Pharma Plc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Royalty Pharma Plc (2002–2023)
Year-by-year Capital Reinvestment Ratio for Royalty Pharma Plc from 2002 to 2023. For live market cap and broader valuation context, see Royalty Pharma Plc (RPRX) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.71x | $2.99 Billion | $2.12 Billion | ▼ -25.6% |
| 2022 | 0.95x | $2.14 Billion | $2.04 Billion | ▲ +367160.5% |
| 2021 | 0.00x | $2.02 Billion | $523.00K | ▼ -100.0% |
| 2020 | 1.08x | $2.03 Billion | $2.20 Billion | ▲ +4.6% |
| 2019 | 1.03x | $1.67 Billion | $1.72 Billion | ▲ +519.7% |
| 2018 | 0.17x | $1.62 Billion | $269.59 Million | ▼ -89.7% |
| 2017 | 1.62x | $1.42 Billion | $2.29 Billion | ▲ +27735.6% |
| 2002 | 0.01x | $8.45 Million | $49.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow